InsidersTradesSigma
Follow the ARC share price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Operating in the Health Care sector, ARC has recorded 7 reports. Market capitalisation: €5m. The latest transaction was reported on 9 September 2026 (Purchase). Among the most active insiders: Michael Walker. The full history is openly available.
7
Insider Decl.
n/a
Thresholds
€100,086
3 ops.
Buy Volume
n/a
n/a
Sell Volume
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 September 2026
Declarations7 total
240,454 shares@ A$0.2629ShareASXASX:2924-03133707-2A1696349
29,510 shares0.0000% mcap100.0% of flowShareASXASX:2924-03101842-2A1678187
ShareASXASX:2924-03101143-2A1677850
1.85% mcap100.0% of flowShareASXASX:2924-03100774-2A1677678
7 of 7 declarations
关于 ARC
ARC 是一家在 XASX 市场上市的医疗保健和制药公司。它专注于开发创新解决方案以改善医疗保健。